The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Tattoo
Tattoo Cream · LIDOCAINE 5 g/100g; EPINEPHRINE 1 g/100g · Cream · Cutaneous · Perfso (HK) Co., Limited
NDC 85942-0001-01 · 10 g in 1 BOX · OTC MONOGRAPH DRUG · View full market →
Medicare Part D
Medicare Part D does not cover over-the-counter drugs — by law it pays only for products requiring a prescription.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Regulatory
- Application
- M017
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Tattoo Cream (Cream)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Perfso (HK) Co., Limited | LIDOCAINE 5 g/100g; EPINEPHRINE 1 g/100g | Aug 26, 2026 | Sep 2, 2026 |
| Perfso (HK) Co., Limited | LIDOCAINE 1 g/100g; EPINEPHRINE 5 g/100g | Jul 22, 2026 | Aug 19, 2026 |
| Perfso (HK) Co., Limited | EPINEPHRINE 1 g/100g; LIDOCAINE 5 g/100g | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Tattoo — NDC 85942-0001-01," retrieved September 3, 2026, https://drugdashboards.com/drug/85942000101.
Free to cite with attribution — see how the data is put together.